Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 02, 2023	Nov. 26, 2022	Dec. 02, 2023	Nov. 26, 2022
Operating activities:
Net (loss) income	$ (1,797)	$ 5,549	$ (570)	$ 11,873
Adjustments to reconcile net (loss) income to cash provided by (used in) operating activities:
Depreciation and amortization	1,116	893	2,114	1,776
Inventory provisions	192	124	277	195
Share-based compensation expense	283	213	766	524
Loss (gain) on disposal of assets	70	(25)	70	(25)
Deferred income taxes	51	27	46	28
Change in assets and liabilities:
Accounts receivable	1,790	(2,009)	6,252	(5,505)
Inventories	(3,069)	(7,658)	(6,220)	(18,126)
Prepaid expenses and other assets	(618)	774	(209)	(425)
Accounts payable	1,233	(699)	(1,132)	796
Accrued liabilities	1,502	(1,062)	378	1,147
Other	47	(49)	43	589
Net cash provided by (used in) operating activities	800	(3,922)	1,815	(7,153)
Investing activities:
Capital expenditures	(1,515)	(1,301)	(2,656)	(2,743)
Proceeds from sale of property, plant & equipment	0	193	0	193
Net cash used in investing activities	(1,515)	(1,108)	(2,656)	(2,550)
Financing activities:
Proceeds from issuance of common stock	15	1,517	342	2,902
Cash dividends paid on Common and Class B Common shares	(845)	(831)	(1,688)	(1,650)
Other	0	0	(119)	(69)
Net cash (used in) provided by financing activities	(830)	686	(1,465)	1,183
Effect of exchange rate changes on cash and cash equivalents	190	(183)	94	(869)
Decrease in cash and cash equivalents	(1,355)	(4,527)	(2,212)	(9,389)
Cash and cash equivalents at beginning of period	24,124	30,633	24,981	35,495
Cash and cash equivalents at end of period	$ 22,769	$ 26,106	$ 22,769	$ 26,106